cardiac allograft vasculopathy

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transplant; Failure, Heart, Cardiac Allograft Vasculopathy, Rejection Heart Transplant Trial (SGLT2i)

Not yet recruiting
  • Transplant; Failure, Heart
  • +2 more
  • (no location specified)
Nov 19, 2023

Cardiac Allograft Vasculopathy Trial in Canada (ICA, PET)

Not yet recruiting
  • Cardiac Allograft Vasculopathy
  • ICA
  • PET
  • Calgary, Alberta, Canada
  • +4 more
Oct 12, 2023

Microvascular Cardiac Allograft Vasculopathy Trial

Recruiting
  • Cardiac Allograft Vasculopathy
  • Echocardiography
  • +7 more
  • Berlin, Germany
    DHZC Deutsches Herzzentrum der Charité
Apr 12, 2023

Microvascular Disease as Assessed by PET and Graft Injury by

Not yet recruiting
  • Cardiac Allograft Vasculopathy
  • +2 more
  • Blood draw to measure the levels of dd-cf DNA
  • New Haven, Connecticut
    Yale New Haven Health
Mar 6, 2023

Cardiac Allograft Vasculopathy Trial in Seoul

Recruiting
  • Cardiac Allograft Vasculopathy
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Sep 6, 2022

    Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)

    Recruiting
    • Cardiac Allograft Vasculopathy
    • Los Angeles, California
      Ronald Regan UCLA Medical Center
    May 9, 2022

    Cardiac Allograft Vasculopathy Trial in Brno, Prague (Alirocumab, Placebo)

    Recruiting
    • Cardiac Allograft Vasculopathy
    • Brno, Czechia
    • +1 more
    Apr 26, 2022

    Early Post Transplant Cardiac Allograft Vasculopathy

    Active, not recruiting
    • Cardiac Allograft Vasculopathy
      • Ottawa, Ontario, Canada
        University of Ottawa Heart Institute
      Feb 10, 2022

      Cardiac Allograft Vasculopathy, Heart Transplant Trial in Vancouver, Ottawa, Toronto (Placebo, aspirin, Clopidogrel)

      Recruiting
      • Cardiac Allograft Vasculopathy
      • Heart Transplant
      • Placebo
      • +2 more
      • Vancouver, British Columbia, Canada
      • +2 more
      Feb 10, 2022

      Cardiac Allograft Vasculopathy Trial in Italy, Netherlands (Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB))

      Completed
      • Cardiac Allograft Vasculopathy
      • Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
      • Cagliari, Italy
      • +9 more
      Sep 29, 2021

      Donor-derived Cell-Free DNA asBiomarker in Cardiac Allograft

      Completed
      • Cardiac Allograft Vasculopathy
      • Donor-derived Cell Free DNA
      • Majadahonda, Madrid, Spain
        University Hospital Puerta de Hierro
      Sep 15, 2021

      Pediatric Heart Transplantation, Immunosuppression, Chronic Kidney Diseases Trial in United States (Everolimus, Tacrolimus,

      Active, not recruiting
      • Pediatric Heart Transplantation
      • +6 more
      • Birmingham, Alabama
      • +24 more
      Sep 2, 2021

      Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles

      Completed
      • Antibody-mediated Rejection
      • +4 more
      • Los Angeles, California
        Cedars Sinai Medical Center, Heart Institute
      Apr 30, 2021

      A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft

      Completed
      • Cardiac Allograft Vasculopathy
        • Boston, Massachusetts
          Boston Children's Hospital
        Mar 2, 2021

        Cardiac Allograft Vasculopathy Trial in Denmark, Finland, Sweden (Evolocumab, Placebo)

        Recruiting
        • Cardiac Allograft Vasculopathy
        • Copenhagen, Denmark
        • +4 more
        Feb 25, 2021

        Cardiac Allograft Vasculopathy, Heart Transplant Recipients Trial in United States (Rituximab induction/conventional

        Terminated
        • Cardiac Allograft Vasculopathy
        • Heart Transplant Recipients
        • Rituximab induction/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
        • Rituximab placebo/conventional immunosuppression (tacrolimus, MMF, and steroid taper)
        • Beverly Hills, California
        • +23 more
        Aug 12, 2020

        Cardiac Mitochondrial Function After Heart Transplantation

        Enrolling by invitation
        • Cardiac Allograft Vasculopathy
        • +3 more
          • Aarhus, Denmark
            Aarhus University Hospital Department of Cardiology
          Aug 10, 2020

          Cardiac Allograft Vasculopathy, Heart Transplant Rejection Trial in Zagreb (Extracoropreal photopheresis)

          Recruiting
          • Cardiac Allograft Vasculopathy
          • Heart Transplant Rejection
          • Extracoropreal photopheresis
          • Zagreb, Croatia
            UHC Zagreb
          Jan 8, 2020

          Cardiac Allograft Vasculopathy Trial in Minneapolis (Sildenafil, Placebo)

          Withdrawn
          • Cardiac Allograft Vasculopathy
          • Minneapolis, Minnesota
            University of Minnesota Medical Center
          Oct 30, 2019

          piTie-Salpetriere University Hospital

          Completed
          • Cardiac Transplant Disorder
          • +7 more
            • (no location specified)
            Sep 24, 2019

            Cardiac Allograft Vasculopathy Trial in Rochester (Perflutren Lipid Microsphere, RTMPE)

            Completed
            • Cardiac Allograft Vasculopathy
            • Perflutren Lipid Microsphere
            • RTMPE
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            May 27, 2019

            Cardiac Allograft Vasculopathy Trial in Beverly Hills (Thymoglobulin)

            Withdrawn
            • Cardiac Allograft Vasculopathy
            • Beverly Hills, California
              Cedars-Sinai Medical Center
            Mar 12, 2019

            Cardiac Allograft Vasculopathy, Transplanted Heart Complication Trial in Copenhagen (Ivabradine, Placebo)

            Unknown status
            • Cardiac Allograft Vasculopathy
            • Transplanted Heart Complication
            • Copenhagen, Denmark
              Department of Cardiology, Copenhagen University Hospital, Rigsho
            Mar 4, 2019

            Cardiac Allograft Vasculopathy, Chronic Rejection of Cardiac Transplant, Graft Dysfunction Trial in Gothenburg (Diagnostic

            Unknown status
            • Cardiac Allograft Vasculopathy
            • +2 more
            • Diagnostic investigations
            • Gothenburg, Sweden
              Sahlgrenska University Hospital
            Jan 15, 2019

            Cardiac Allograft Vasculopathy, Antibody Mediated Rejection Trial in Pittsburgh (device, drug, procedure)

            Terminated
            • Cardiac Allograft Vasculopathy
            • Antibody Mediated Rejection
            • Optical Coherence Tomography
            • +2 more
            • Pittsburgh, Pennsylvania
              University of Pittsburgh Medical Center
            Sep 1, 2017